Minimally invasive therapy for benign prostatic hyperplasia: Practice patterns in Minnesota

Journal of Endourology

Volumn 19, Issue 2, 2005, Pages 159-162

  Ercole, Barbara ^a   Lee, Courtney ^a   Best, Sara ^a   Fallon, Elizabeth ^a   Skenazy, Jason ^a   Monga, Manoj ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHI SQUARE TEST; CLINICAL PRACTICE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; MANAGED CARE; MEDICAL SOCIETY; MINIMALLY INVASIVE SURGERY; PATIENT REFERRAL; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUESTIONNAIRE; RESIDENCY EDUCATION; RURAL AREA; STATISTICAL ANALYSIS; STUDENT T TEST; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; URBAN AREA;

AGE FACTORS; CATHETER ABLATION; HUMANS; MALE; MINNESOTA; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL PRACTICE LOCATION; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; RURAL HEALTH SERVICES; TRANSURETHRAL RESECTION OF PROSTATE; URBAN HEALTH SERVICES;

EID: 16844367440     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2005.19.159     Document Type: Article

References (13)

1. Aries E. United States Life Tables, 2000: National Vital Statistics Report, Volume 51. Hyattsville, MD: National Center for Health Statistics, 2002.
2. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of benign prostatic hyperplasia with age. J Urol 1984;132:474-479.
3. AUA Guidelines for Management of BPH, 2003. Available at https://shop.auanet.org/timssnet/products/guidelines/bph_management.cfm
4. Larson TR. Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy. Urology 2002;59(suppl 2A):12-16.
5. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, Writing Committee: Transurethral prostatectomy: Immediate and postoperative complications: A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-247.
6. Kahn SA, Alphonse P, Tweari A, Narayan P. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: The University of Florida experience. J Urol 1998;160:1695-1700.
7. Daehlin L, Gustavsen A, Nilsen AH, Mohn J. Transurethral needle ablation for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: Outcome after 1 year. J Endourol 2002;16:111-115.
8. Djavan B, Shariat S, Schafer B, Marberger M. Tolerability of high-energy transurethral microwave thermotherapy with topical urethral anesthesia: Results of prospective, randomized, single blinded clinical trial. J Urol 1998;160:772-776.
9. Williams G, Jager R, McLoughlin J, et al. Use of stents for treating obstruction of urinary outflow in patients unfit for surgery. Br Med J 1989;298:1429.
10. Beduschi MC, Oesterling JE. Transurethral needle ablation of the prostate: A minimally invasive treatment for symptomatic benign prostatic hyperplasia. Mayo Clin Proc 1998;73:696-701.
11. Thalmann GN, Mattei A, Treuthardt C, et al. Transurethral microwave therapy in 200 patients with minimum followup of 2 years: Urodynamic and clinical results. J Urol 2002;167:2496-2501.
12. Muschter R, Schorsch I, Danielli L, Russel C, Timoney A, et al. Transurethral water-induced thermotherapy for the treatment of benign prostatic hyperplasia: A prospective multicenter clinical trial. J Urol 2000;164:1565-1569.
13. Martenson AC, Rosette JJ de la. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode laser system: Results of an evolving technology. Prostate Cancer Prostatic Dis 1999;2:148-154.